Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 515

1.

Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer.

Lang JE, Liu LC, Lu Y, Jenkins T, Hwang SE, Esserman LJ, Ewing CA, Alvarado M, Morita E, Treseler P, Leong SP.

Breast J. 2009 May-Jun;15(3):242-6. doi: 10.1111/j.1524-4741.2009.00712.x.

PMID:
19645778
2.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
3.

Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients.

Tan YY, Fan YG, Lu Y, Hwang S, Ewing C, Esserman L, Morita E, Treseler P, Leong SP.

Breast J. 2005 Jul-Aug;11(4):248-53.

PMID:
15982390
4.
5.

Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.

Saidi RF, Dudrick PS, Remine SG, Mittal VK.

Am Surg. 2004 Feb;70(2):101-5; discussion 105.

PMID:
15011910
6.

Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.

Gur AS, Unal B, Johnson R, Ahrendt G, Bonaventura M, Gordon P, Soran A.

J Am Coll Surg. 2009 Feb;208(2):229-35. doi: 10.1016/j.jamcollsurg.2008.10.029. Epub 2008 Dec 18.

PMID:
19228534
7.

Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.

Bassi KK, Seenu V, Ballehaninna UK, Parshad R, Chumber S, Dhar A, Gupta SD, Kumar R, Srivastava A.

Indian J Cancer. 2006 Jul-Sep;43(3):103-9.

8.

Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.

Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A.

Eur J Surg Oncol. 2006 Feb;32(1):29-33. Epub 2005 Nov 2.

PMID:
16269227
9.

How 'hot' is the pathologically positive sentinel lymph node in breast cancer patients?

Bourgeois P, Nogaret JM, Veys I, Hertens D, Dagnelie J, Vanhaudenaerde C, Verdebout JM, Larsimont D.

Nucl Med Commun. 2003 May;24(5):513-8.

PMID:
12717067
10.

Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.

Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI.

Ann Surg Oncol. 2003 Apr;10(3):248-54.

PMID:
12679309
11.

The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.

Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP.

Ann Surg Oncol. 2005 Sep;12(9):705-11. Epub 2005 Aug 4. Erratum in: Ann Surg Oncol. 2005 Nov;12(11):952.

PMID:
16079953
12.
13.

Predicting the status of the nonsentinel axillary nodes: a multicenter study.

Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Woo C, Cerrito PB, McMasters KM; University of Louisville Breast Cancer Sentinel Lymph Node Study Group.

Arch Surg. 2001 May;136(5):563-8.

PMID:
11343548
14.

Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?

Zakaria S, Pantvaidya G, Reynolds CA, Grant CS, Sterioff S, Donohue JH, Farley DR, Hoskin TL, Degnim AC.

Surgery. 2008 May;143(5):641-7. doi: 10.1016/j.surg.2007.10.023. Epub 2008 Feb 13.

PMID:
18436012
15.

Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.

Tan YY, Wu CT, Fan YG, Hwang S, Ewing C, Lane K, Esserman L, Lu Y, Treseler P, Morita E, Leong SP.

Breast J. 2005 Sep-Oct;11(5):338-43.

PMID:
16174155
16.

Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.

Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, Pilati P, Lise M, Nitti D, Rizzo E, Montesco MC.

Ann Surg Oncol. 2008 Apr;15(4):1202-10. doi: 10.1245/s10434-007-9734-8. Erratum in: Ann Surg Oncol. 2008 May;15(5):1552.

PMID:
18165880
17.

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.

Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK.

Cancer. 2007 Aug 15;110(4):723-30.

18.

The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.

Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS.

Ann Surg Oncol. 2009 Aug;16(8):2245-51. doi: 10.1245/s10434-009-0530-5. Epub 2009 Jun 11.

PMID:
19517194
19.

Selective sentinel lymphadenectomy for breast cancer in the United States.

Leong SP.

Asian J Surg. 2004 Oct;27(4):268-74. Review.

20.

Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.

Jinno H, Sakata M, Asaga S, Wada M, Shimada T, Kitagawa Y, Suzuki T, Nakahara T, Kitamura N, Kubo A, Mukai M, Ikeda T, Kitajima M.

Breast J. 2008 Nov-Dec;14(6):551-5. doi: 10.1111/j.1524-4741.2008.00646.x. Epub 2008 Oct 13.

PMID:
19000054
Items per page

Supplemental Content

Write to the Help Desk